{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:29:06Z","timestamp":1761596946330,"version":"3.32.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.neuroscience.2005.12.004","type":"journal-article","created":{"date-parts":[[2006,1,20]],"date-time":"2006-01-20T12:41:51Z","timestamp":1137760911000},"page":"1161-1170","source":"Crossref","is-referenced-by-count":49,"title":["In vivo protection by the xanthate tricyclodecan-9-yl-xanthogenate against amyloid \u03b2-peptide (1\u201342)-induced oxidative stress"],"prefix":"10.1016","volume":"138","author":[{"given":"M.","family":"Perluigi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Sultana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Calabrese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"De Marco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Coccia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.A.","family":"Butterfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.neuroscience.2005.12.004_bib1","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1523\/JNEUROSCI.23-12-05088.2003","article-title":"Changes in intracellular calcium and glutathione in astrocytes as the primary mechanism of amyloid neurotoxicity","volume":"23","author":"Abramov","year":"2003","journal-title":"J Neurosci"},{"issue":"8","key":"10.1016\/j.neuroscience.2005.12.004_bib2","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1212\/WNL.57.8.1515","article-title":"Controlled trial of N-acetylcysteine for patients with probable Alzheimer\u2019s disease","volume":"57","author":"Adair","year":"2001","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.neuroscience.2005.12.004_bib3","doi-asserted-by":"crossref","first-page":"7918","DOI":"10.1074\/jbc.275.11.7918","volume":"275","author":"Akama","year":"2000","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.neuroscience.2005.12.004_bib4","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0306-4522(00)00580-7","article-title":"Protein oxidation in the brain in Alzheimer\u2019s disease","volume":"103","author":"Aksenov","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2005.12.004_bib5","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.mito.2004.07.018","article-title":"Mitochondria as a primary target for vascular hypoperfusion and oxidative stress in Alzheimer\u2019s disease","volume":"4","author":"Aliev","year":"2004","journal-title":"Mitochondrion"},{"issue":"1","key":"10.1016\/j.neuroscience.2005.12.004_bib6","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.abb.2003.11.002","article-title":"A role for supplements in optimizing health","volume":"423","author":"Ames","year":"2004","journal-title":"Arch Biochem Biophys"},{"issue":"9","key":"10.1016\/j.neuroscience.2005.12.004_bib7","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/0006-2952(87)90124-9","article-title":"Synergistic antiviral effect of xanthates and ionic detergents","volume":"36","author":"Amtmann","year":"1987","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"10.1016\/j.neuroscience.2005.12.004_bib8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0304-3835(87)90125-X","article-title":"Selective killing of tumor cells by xanthates","volume":"35","author":"Amtmann","year":"1987","journal-title":"Cancer Lett"},{"issue":"4","key":"10.1016\/j.neuroscience.2005.12.004_bib9","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1055\/s-2007-1007174","article-title":"Glutathione therapy","volume":"18","author":"Anderson","year":"1998","journal-title":"Semin Liver Dis"},{"issue":"3","key":"10.1016\/j.neuroscience.2005.12.004_bib10","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.freeradbiomed.2004.04.007","article-title":"Inflammatory mediator and beta-amyloid (25\u201335)-induced ceramide generation and iNOS expression are inhibited by vitamin E","volume":"37","author":"Ayasolla","year":"2004","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.neuroscience.2005.12.004_bib11","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/978-1-4615-0123-7_18","article-title":"Neuroprotective strategies in Alzheimer\u2019s disease","volume":"513","author":"Behl","year":"2002","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"10.1016\/j.neuroscience.2005.12.004_bib12","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/0006-291X(92)90837-B","article-title":"Vitamin E protects nerve cells from amyloid beta protein toxicity","volume":"186","author":"Behl","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"10.1016\/j.neuroscience.2005.12.004_bib13","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1124\/mol.51.4.535","article-title":"Neuroprotection against oxidative stress by estrogens","volume":"51","author":"Behl","year":"1997","journal-title":"Mol Pharmacol"},{"issue":"4","key":"10.1016\/j.neuroscience.2005.12.004_bib14","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/0197-4580(95)00066-N","article-title":"Are reactive oxygen species involved in Alzheimer\u2019s disease?","volume":"16","author":"Benzi","year":"1995","journal-title":"Neurobiol Aging"},{"issue":"33","key":"10.1016\/j.neuroscience.2005.12.004_bib15","doi-asserted-by":"crossref","first-page":"20313","DOI":"10.1074\/jbc.272.33.20313","article-title":"Protein oxidation in aging, disease, and oxidative stress","volume":"272","author":"Berlett","year":"1997","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.neuroscience.2005.12.004_bib16","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/jnr.20394","article-title":"Gamma-glutamylcysteine ethyl ester-induced up-regulation of glutathione protects neurons against Abeta(1\u201342)-mediated oxidative stress and neurotoxicity","volume":"79","author":"Boyd-Kimball","year":"2005","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neuroscience.2005.12.004_bib17","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev.med.47.1.401","article-title":"The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer\u2019s disease","volume":"47","author":"Breitner","year":"1996","journal-title":"Annu Rev Med"},{"issue":"5","key":"10.1016\/j.neuroscience.2005.12.004_bib18","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1021\/tx960130e","article-title":"beta-Amyloid-associated free radical oxidative stress and neurotoxicity","volume":"10","author":"Butterfield","year":"1997","journal-title":"Chem Res Toxicol"},{"issue":"8","key":"10.1016\/j.neuroscience.2005.12.004_bib19","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0955-2863(02)00205-X","article-title":"Nutritional approaches to combat oxidative stress in Alzheimer\u2019s disease","volume":"13","author":"Butterfield","year":"2002","journal-title":"J Nutr Biochem"},{"issue":"12","key":"10.1016\/j.neuroscience.2005.12.004_bib20","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1080\/1071576021000049890","article-title":"Amyloid beta-peptide (1\u201342)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer\u2019s disease brain. A review","volume":"36","author":"Butterfield","year":"2002","journal-title":"Free Radic Res"},{"issue":"6","key":"10.1016\/j.neuroscience.2005.12.004_bib21","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1046\/j.1471-4159.2003.01948.x","article-title":"Proteomics in Alzheimer\u2019s disease","volume":"86","author":"Butterfield","year":"2003","journal-title":"J Neurochem"},{"issue":"12","key":"10.1016\/j.neuroscience.2005.12.004_bib22","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S1471-4914(01)02173-6","article-title":"Evidence of oxidative damage in Alzheimer\u2019s disease brain","volume":"7","author":"Butterfield","year":"2001","journal-title":"Trends Mol Med"},{"issue":"11","key":"10.1016\/j.neuroscience.2005.12.004_bib23","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S0891-5849(02)00794-3","article-title":"Lipid peroxidation and protein oxidation in Alzheimer\u2019s disease brain","volume":"32","author":"Butterfield","year":"2002","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"10.1016\/j.neuroscience.2005.12.004_bib24","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1089\/ars.2004.6.895","article-title":"Redox regulation in neurodegeneration and longevity","volume":"6","author":"Calabrese","year":"2004","journal-title":"Antioxid Redox Signal"},{"issue":"3","key":"10.1016\/j.neuroscience.2005.12.004_bib25","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1023\/B:NERE.0000014834.06405.af","article-title":"Toxicity of amyloid beta peptide","volume":"29","author":"Canevari","year":"2004","journal-title":"Neurochem Res"},{"issue":"6","key":"10.1016\/j.neuroscience.2005.12.004_bib26","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1046\/j.1471-4159.2003.01786.x","article-title":"Proteomic identification of nitrated proteins in Alzheimer\u2019s disease brain","volume":"85","author":"Castegna","year":"2003","journal-title":"J Neurochem"},{"issue":"1","key":"10.1016\/j.neuroscience.2005.12.004_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0301-0082(95)00029-1","article-title":"Oxidative stress and antioxidant therapy in Parkinson\u2019s disease","volume":"48","author":"Ebadi","year":"1996","journal-title":"Prog Neurobiol"},{"issue":"1","key":"10.1016\/j.neuroscience.2005.12.004_bib28","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0891-5849(91)90192-6","article-title":"Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes","volume":"11","author":"Esterbauer","year":"1991","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"10.1016\/j.neuroscience.2005.12.004_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1385\/JMN:21:1:1","article-title":"Antioxidant treatment in Alzheimer\u2019s disease","volume":"21","author":"Gilgun-Sherki","year":"2003","journal-title":"J Mol Neurosci"},{"issue":"2","key":"10.1016\/j.neuroscience.2005.12.004_bib30","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0006-291X(88)80538-2","article-title":"Amyloid fibrils formed from a segment of the pancreatic islet amyloid protein","volume":"155","author":"Glenner","year":"1988","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.neuroscience.2005.12.004_bib31","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","article-title":"Alzheimer\u2019s disease","volume":"120","author":"Glenner","year":"1984","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.neuroscience.2005.12.004_bib32","first-page":"21","article-title":"Evidence of neuronal oxidative damage in Alzheimer\u2019s disease","volume":"149","author":"Good","year":"1996","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.neuroscience.2005.12.004_bib33","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1046\/j.1471-4159.1996.66051836.x","article-title":"Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons","volume":"66","author":"Goodman","year":"1996","journal-title":"J Neurochem"},{"issue":"2","key":"10.1016\/j.neuroscience.2005.12.004_bib34","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1079\/PNS2002146","article-title":"Antioxidant strategies for Alzheimer\u2019s disease","volume":"61","author":"Grundman","year":"2002","journal-title":"Proc Nutr Soc"},{"issue":"5441","key":"10.1016\/j.neuroscience.2005.12.004_bib35","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1126\/science.286.5441.916","article-title":"The presenilins in Alzheimer\u2019s disease","volume":"286","author":"Haass","year":"1999","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.neuroscience.2005.12.004_bib36","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2165\/00002512-200118090-00004","article-title":"Role of free radicals in the neurodegenerative diseases","volume":"18","author":"Halliwell","year":"2001","journal-title":"Drugs Aging"},{"issue":"10","key":"10.1016\/j.neuroscience.2005.12.004_bib37","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","article-title":"Amyloid deposition as the central event in the aetiology of Alzheimer\u2019s disease","volume":"12","author":"Hardy","year":"1991","journal-title":"Trends Pharmacol Sci"},{"issue":"8","key":"10.1016\/j.neuroscience.2005.12.004_bib38","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.freeradbiomed.2004.12.027","article-title":"In vivo protection of synaptosomes from oxidative stress mediated by Fe2+\/H2O2 or 2,2-azobis-(2-amidinopropane) dihydrochloride by the glutathione mimetic tricyclodecan-9-yl-xanthogenate","volume":"38","author":"Joshi","year":"2005","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"10.1016\/j.neuroscience.2005.12.004_bib39","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1046\/j.1471-4159.2000.0741579.x","article-title":"Amyloid beta-peptide effects on synaptosomes from apolipoprotein E-deficient mice","volume":"74","author":"Keller","year":"2000","journal-title":"J Neurochem"},{"issue":"4","key":"10.1016\/j.neuroscience.2005.12.004_bib40","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/1071576021000040664","article-title":"Derivatives of xanthic acid are novel antioxidants","volume":"37","author":"Lauderback","year":"2003","journal-title":"Free Radic Res"},{"issue":"2","key":"10.1016\/j.neuroscience.2005.12.004_bib41","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1046\/j.1471-4159.2001.00451.x","article-title":"The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer\u2019s disease brain","volume":"78","author":"Lauderback","year":"2001","journal-title":"J Neurochem"},{"issue":"4","key":"10.1016\/j.neuroscience.2005.12.004_bib42","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0891-5849(99)00269-5","article-title":"Age-associated decline in gamma-glutamylcysteine synthetase gene expression in rats","volume":"28","author":"Liu","year":"2000","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.neuroscience.2005.12.004_bib43","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2174\/1568007054038210","article-title":"Preventing activation of receptor for advanced glycation endproducts in Alzheimer\u2019s disease","volume":"4","author":"Lue","year":"2005","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"issue":"2","key":"10.1016\/j.neuroscience.2005.12.004_bib44","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1084\/jem.184.2.725","article-title":"Function of the p55 tumor necrosis factor receptor \u201cdeath domain\u201d mediated by phosphatidylcholine-specific phospholipase C","volume":"184","author":"Machleidt","year":"1996","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.neuroscience.2005.12.004_bib45","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.abb.2003.08.037","article-title":"Antioxidants in myocardial ischemia-reperfusion injury","volume":"420","author":"Marczin","year":"2003","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"10.1016\/j.neuroscience.2005.12.004_bib46","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0891-5849(96)00629-6","article-title":"Oxidative stress hypothesis in Alzheimer\u2019s disease","volume":"23","author":"Markesbery","year":"1997","journal-title":"Free Radic Biol Med"},{"issue":"10","key":"10.1016\/j.neuroscience.2005.12.004_bib47","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0166-2236(93)90009-B","article-title":"beta-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer\u2019s disease","volume":"16","author":"Mattson","year":"1993","journal-title":"Trends Neurosci"},{"issue":"2","key":"10.1016\/j.neuroscience.2005.12.004_bib48","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.yexcr.2003.10.001","article-title":"Sphingomyelin synthase as a potential target for D609-induced apoptosis in U937 human monocytic leukemia cells","volume":"292","author":"Meng","year":"2004","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.neuroscience.2005.12.004_bib49","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1196\/annals.1333.062","article-title":"Oxidative stress and neurodegeneration","volume":"1043","author":"Moreira","year":"2005","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"10.1016\/j.neuroscience.2005.12.004_bib50","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1523\/JNEUROSCI.17-05-01683.1997","article-title":"Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide","volume":"17","author":"Pappolla","year":"1997","journal-title":"J Neurosci"},{"issue":"7","key":"10.1016\/j.neuroscience.2005.12.004_bib51","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.freeradbiomed.2004.12.021","article-title":"Proteomic analysis of 4-hydroxy-2-nonenal-modified proteins in G93A-SOD1 transgenic mice-a model of familial amyotrophic lateral sclerosis","volume":"38","author":"Perluigi","year":"2005","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"10.1016\/j.neuroscience.2005.12.004_bib52","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0197-0186(01)00012-2","article-title":"Glutathione elevation and its protective role in acrolein-induced protein damage in synaptosomal membranes","volume":"39","author":"Pocernich","year":"2001","journal-title":"Neurochem Int"},{"issue":"3","key":"10.1016\/j.neuroscience.2005.12.004_bib53","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0197-0186(99)00126-6","article-title":"In-vivo glutathione elevation protects against hydroxyl free radical-induced protein oxidation in rat brain","volume":"36","author":"Pocernich","year":"2000","journal-title":"Neurochem Int"},{"issue":"6","key":"10.1016\/j.neuroscience.2005.12.004_bib54","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/00019052-199912000-00017","article-title":"Multiple antioxidants in the prevention and treatment of neurodegenerative disease","volume":"12","author":"Prasad","year":"1999","journal-title":"Curr Opin Neurol"},{"year":"1971","series-title":"Xanthates and related compounds","author":"Rao","key":"10.1016\/j.neuroscience.2005.12.004_bib55"},{"issue":"5","key":"10.1016\/j.neuroscience.2005.12.004_bib56","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/0092-8674(92)90553-O","article-title":"TNF activates NF-kappa B by phosphatidylcholine-specific phospholipase C-induced \u201cacidic\u201d sphingomyelin breakdown","volume":"71","author":"Schutze","year":"1992","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.neuroscience.2005.12.004_bib57","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","article-title":"Alzheimer\u2019s disease","volume":"81","author":"Selkoe","year":"2001","journal-title":"Physiol Rev"},{"issue":"9","key":"10.1016\/j.neuroscience.2005.12.004_bib58","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1097\/00005072-199909000-00008","article-title":"Accumulation of amyloid beta and tau and the formation of neurofilament inclusions following diffuse brain injury in the pig","volume":"58","author":"Smith","year":"1999","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"10.1016\/j.neuroscience.2005.12.004_bib59","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3233\/JAD-2003-5404","article-title":"Elevation of oxidative free radicals in Alzheimer\u2019s disease models can be attenuated by Ginkgo biloba extract EGb 761","volume":"5","author":"Smith","year":"2003","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"10.1016\/j.neuroscience.2005.12.004_bib60","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1021\/tx960133r","article-title":"Reactive oxygen-mediated protein oxidation in aging and disease","volume":"10","author":"Stadtman","year":"1997","journal-title":"Chem Res Toxicol"},{"issue":"3","key":"10.1016\/j.neuroscience.2005.12.004_bib61","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1046\/j.1471-4159.1997.69031161.x","article-title":"The lipid peroxidation product, 4-hydroxy-2-trans-nonenal, alters the conformation of cortical synaptosomal membrane proteins","volume":"69","author":"Subramaniam","year":"1997","journal-title":"J Neurochem"},{"issue":"5","key":"10.1016\/j.neuroscience.2005.12.004_bib62","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1080\/1071576042000206478","article-title":"Protective effect of the xanthate, D609, on Alzheimer\u2019s amyloid beta-peptide (1\u201342)-induced oxidative stress in primary neuronal cells","volume":"38","author":"Sultana","year":"2004","journal-title":"Free Radic Res"},{"key":"10.1016\/j.neuroscience.2005.12.004_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2005.09.021","article-title":"Region redox proteomics to identify oxidized protein in Alzheimer\u2019s disease brain","author":"Sultana","year":"2006","journal-title":"Neurobiol Aging"},{"issue":"2\u20133","key":"10.1016\/j.neuroscience.2005.12.004_bib64","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1006\/jsbi.2000.4274","article-title":"Review","volume":"130","author":"Varadarajan","year":"2000","journal-title":"J Struct Biol"},{"issue":"1","key":"10.1016\/j.neuroscience.2005.12.004_bib65","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0042-6822(91)90474-P","article-title":"Antiviral effects of xanthate D609 on the human respiratory syncytial virus growth cycle","volume":"181","author":"Villanueva","year":"1991","journal-title":"Virology"},{"issue":"1\u20132","key":"10.1016\/j.neuroscience.2005.12.004_bib66","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.mam.2004.02.013","article-title":"Molecular bases of the treatment of Alzheimer\u2019s disease with antioxidants","volume":"25","author":"Vina","year":"2004","journal-title":"Mol Aspects Med"},{"issue":"6","key":"10.1016\/j.neuroscience.2005.12.004_bib67","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/0092-8674(94)90275-5","article-title":"Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling","volume":"78","author":"Wiegmann","year":"1994","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.neuroscience.2005.12.004_bib68","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1385\/JMN:15:2:85","article-title":"Pivotal role for acidic sphingomyelinase in cerebral ischemia-induced ceramide and cytokine production, and neuronal apoptosis","volume":"15","author":"Yu","year":"2000","journal-title":"J Mol Neurosci"},{"issue":"1","key":"10.1016\/j.neuroscience.2005.12.004_bib69","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0022-3565(24)29356-3","article-title":"D609 inhibits ionizing radiation-induced oxidative damage by acting as a potent antioxidant","volume":"298","author":"Zhou","year":"2001","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452205013850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452205013850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T08:19:12Z","timestamp":1736237952000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452205013850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":69,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0306452205013850"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2005.12.004","relation":{},"ISSN":["0306-4522"],"issn-type":[{"type":"print","value":"0306-4522"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}